Project Details
| Short title | MK-6482-024 |
|---|---|
| Acronym | Litespark |
| Status | Active |
| Effective start/end date | 3/08/22 → 18/07/27 |
CTU A Multicenter, Open-label, Randomized, Phase 1/2 Study of Belzutifan in Combination with Palbociclib Versus Belzutifan Monotherapy in Participants with Advanced Renal Cell Carcinoma
- Gurney, Howard (Primary Chief Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Chester, Catherine (Clinical Trial Unit Staff)
Project: Research